the time trade-off. Journal of Clinical Epidemiology 60(10): 1029-1033, 10/2007.

46.Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S, Lehmann KA, Cleeland CS. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 18(3): 180-187, 9/1999.

47.Radbruch L, Sabatowski R, Loick G, Jonen-Thielemann I, Elsner F, Hormann E. [MIDOS--validation of a minimal documentation system for palliative medicine]. Schmerz 14(4): 231-239, 8/2000.

48.Raichle KA, Osborne TL, Jensen MP, Cardenas D. The reliability and validity of pain interference measures in persons with spinal cord injury. J Pain 7(3): 179-186, 3/2006.

49.Rutledge DN, Jones CJ. Effects of topical essential oil on exercise volume after a 12-week exercise program for women with fibromyalgia: A pilot study. Journal of Alternative and Complementary Medicine 13(10): 1099-1106, 12/2007.

50.Saxena A, Mendoza T, Cleeland CS. The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. J Pain Symptom Manage 17(1): 27-41, 1/1999.

51.Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J, Onetto N, Ren L, Grechko J, Beltangady M, . Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factor. J Natl Cancer Inst 87(17): 1316-1322, 9/1995.

52.Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61(2): 277- 284, 5/1995.

53.Shin H, Kim K, Young HK, Chee W, Im EO. A comparison of two pain measures for Asian American cancer patients. West J Nurs Res 29(5): 545-560, 8/2007.

54.Shin H, Kim K, Young HK, Chee W, Im EO. A comparison of two pain measures for asian american cancer patients. West J Nurs Res 30(2): 181-196, 3/2008.

55.Smith BH, Torrance N, Bennett MI, Lee AJ. Health and Quality of Life Associated With Chronic Pain of Predominantly Neuropathic Origin in the Community. Clin J Pain 23(2): 143- 149, 2/2007.

56.Su L, Tucker R, Frey SE, Gress JO, Chan IS, Kuter BJ, Guess HA. Measuring injection-site pain associated with vaccine administration in adults: a randomised, double-blind, placebo-controlled clinical trial. J Epidemiol Biostat 5(6): 359- 365, 2000.

57.Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 5(2): 133- 137, 3/2004.

58.Tittle MB, McMillan SC, Hagan S. Validating the brief pain inventory for use with surgical patients with cancer. Oncol Nurs Forum 30(2): 325-330, 3/2003.

59.Tyler EJ, Jensen MP, Engel JM, Schwartz L. The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil 83(2): 236-239, 2/2002.

60.Tzeng JI, Chang CC, Chang HJ, Lin CC. Assessing Analgesic Regimen Adherence with the Morisky Medication Adherence Measure for Taiwanese Patients with Cancer Pain. J Pain Symptom Manage, 4/2008.

61.Uki J, Mendoza T, Cleeland CS, Nakamura Y, Takeda F. A brief cancer pain assessment tool in Japanese: the utility of the Japanese Brief Pain Inventory--BPI-J. J Pain Symptom Manage 16(6): 364-373, 12/1998.

62.Wang XS, Mendoza TR, Gao SZ, Cleeland CS. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain 67(2-3): 407-416, 10/1996.

63.Williams VS, Smith MY, Fehnel SE. The validity and utility of the BPI interference measures for evaluating the impact of

55

56

Page 30
Image 30
AB Soft ii manual